Clinical trial
Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block
NCT05767827 is registered in ClinicalTrials.gov with Nepal Medical College and Teaching Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block
- Lead sponsor
- Nepal Medical College and Teaching Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2023
- Completion date
- August 30, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brachial plexus block, local anesthesia adjuvants, upper extremity fracture